ATE127017T1 - Castanosperminester zur behandlung der zerebralen malaria. - Google Patents

Castanosperminester zur behandlung der zerebralen malaria.

Info

Publication number
ATE127017T1
ATE127017T1 AT90119842T AT90119842T ATE127017T1 AT E127017 T1 ATE127017 T1 AT E127017T1 AT 90119842 T AT90119842 T AT 90119842T AT 90119842 T AT90119842 T AT 90119842T AT E127017 T1 ATE127017 T1 AT E127017T1
Authority
AT
Austria
Prior art keywords
treatment
cells
falciparum
cause
cerebral malaria
Prior art date
Application number
AT90119842T
Other languages
English (en)
Inventor
Alan J Bitonti
Albert Sjoerdsma
Peter P Mccann
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE127017T1 publication Critical patent/ATE127017T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT90119842T 1989-10-17 1990-10-16 Castanosperminester zur behandlung der zerebralen malaria. ATE127017T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42286989A 1989-10-17 1989-10-17

Publications (1)

Publication Number Publication Date
ATE127017T1 true ATE127017T1 (de) 1995-09-15

Family

ID=23676762

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90119842T ATE127017T1 (de) 1989-10-17 1990-10-16 Castanosperminester zur behandlung der zerebralen malaria.

Country Status (8)

Country Link
EP (1) EP0423728B1 (de)
JP (1) JPH03133930A (de)
KR (1) KR100188799B1 (de)
AT (1) ATE127017T1 (de)
AU (1) AU628228B2 (de)
DE (1) DE69021980T2 (de)
IE (1) IE67048B1 (de)
ZA (1) ZA908134B (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1315276C (en) * 1987-07-02 1993-03-30 Paul S. Liu Castanospermine esters and glycosides
US5004746A (en) * 1987-09-29 1991-04-02 Merrell Dow Pharmaceuticals Inc. Anti-retroviral castanospermine esters
AU618838B2 (en) * 1988-08-10 1992-01-09 Praxis Pharmaceuticals, Inc. Use of castanospermine as an anti-inflammatory and immunosuppressant agent

Also Published As

Publication number Publication date
ZA908134B (en) 1991-07-31
DE69021980T2 (de) 1996-02-15
KR910007529A (ko) 1991-05-30
EP0423728A2 (de) 1991-04-24
IE903711A1 (en) 1991-04-24
IE67048B1 (en) 1996-02-21
AU6453290A (en) 1991-04-26
JPH03133930A (ja) 1991-06-07
DE69021980D1 (de) 1995-10-05
AU628228B2 (en) 1992-09-10
EP0423728B1 (de) 1995-08-30
EP0423728A3 (en) 1993-02-03
KR100188799B1 (ko) 1999-06-01

Similar Documents

Publication Publication Date Title
DE59005568D1 (de) Pyridyl-substituierte Acrylsäureester.
DE69020708D1 (de) Verfahren zur Herstellung von biMOS-Halbleiterbauelementen mit verbesserter Schnelligkeit und Zuverlässigkeit.
ES2073533T3 (es) Uso antivirico de composiciones que constan de acidos grasos esenciales e interferon.
DE3872308D1 (de) Polymerisation von acrylestern.
DE69009237D1 (de) Verfahren zur Herstellung von optisch aktiven Estern der 6-t-Butoxy-3,5-dihydroxyhexansäure.
DK561089A (da) Anvendelse af lactamimider til fremstilling af laegemidler
DE59302422D1 (de) Verfahren zur Herstellung von Copolymerisaten des Ethylens mit Acrylsäureestern
DK0667155T3 (da) Tabletter med thioctsyre med bestemt kornstørrelse
DK0647229T3 (da) Diaminsalte af clavulansyre
ATE127017T1 (de) Castanosperminester zur behandlung der zerebralen malaria.
ATE126435T1 (de) Antiherpes-castanosperminester.
DE59007013D1 (de) Substituierte Acrylsäureester.
IT1229482B (it) Acidi (rs) 2 (2,3 diidro 5 idrossi 4,6,7 trimetilbenzofuranil) acetico e 2 (2,3 diidro 5 acilossi 4,6,7 trimetilbenzofuranil) acetici e loro esteri, utili come farmaci mucoregolatori ed antiischemici.
NO924637L (no) Fremgangsmaate ved forhindring av gjentilstopping av arterier
DE59006594D1 (de) Heterocyclisch sustituierte Acrylsäureester.
BR8802307A (pt) Composto de derivados monomericos e oligomericos de esteres dialquilicos estabilizadores de resinas sinteticas,composicao polimerica sintetica e composto
DE58902314D1 (de) Substituierte acrylsaeureester.
NO881214D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk preparat med virkning paa hjerte- og karsystemet.
IT8820990A0 (it) Esteri penem 6 sostituiti come agenti antinfiammatori e antidegenerativi.
DE59002503D1 (de) Niedermolekulare Polymerisate von Acrylsäureestern.
DE69012510D1 (de) Verfahren zur Herstellung von Optisch aktiven Fluor enthaltenden Estern der 3-Hydroxybuttersäure.
DE68914233D1 (de) Verfahren zur Herstellung von Estern von Tricyclodekancarbonsäuren.
IT8123391A0 (it) Processo per la preparazione di esteri di acidi arilpropionici otticamente attivi.
DE68912432D1 (de) Pharmazeutische Zusammensetzung, verwendbar bei der Behandlung von Herzgefässerkrankungen.
ATE98665T1 (de) Heissschmelzkleber-zusammensetzungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee